¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"cellular immunity deficiency syndrome"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • battered child syndrome
    ÇÇÇÐ´ë¾ÆÁõÈıº, ¸Å¸Â´Â¾ÆÀÌÁõÈıº
  • Beckwith¡¯s syndrome
    º¤À§½ºÁõÈıº
  • blind loop syndrome
    ¸·Èù°í¸®ÁõÈıº, ¸Í°üÁõÈıº
  • brain death syndrome
    ³ú»çÁõÈıº
  • branchial arch syndrome
    ÀεαÁÀÌÁõÈıº, »õ±ÃÁõÈıº
  • branchio-oto-renal syndrome
    ¾Æ°¡¹Ì±ÍÄáÆÏÁõÈıº
  • brittle hair syndrome
    Ãë¾à¸ð¹ßÁõÈıº
  • bronze baby syndrome
    ûµ¿»ö¾Æ±âÁõÈıº
  • Brown-Sequard syndrome
    ºê¶ó¿î-¼¼Ä«¸£ÁõÈıº
  • burning tongue syndrome
    ÇôÈ­²öÁõÈıº
  • clumsy child syndrome
    µÐÇѾƵ¿ÁõÈıº
  • capsular block syndrome
    ÇǸ·Æó¼âÁõÈıº
  • combined immunodeficiency syndrome
    º¹Çո鿪°áÇÌÁõÈıº
  • compartment syndrome
    ±¸È¹ÁõÈıº
  • complex regional pain syndrome
    º¹ÇÕºÎÀ§ÅëÁõÁõÈıº
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • alveolar-capillary block syndrome
    ÆóÆ÷¸ð¼¼Ç÷°üÂ÷´ÜÁõÈıº
  • amnestic syndrome
    ±â¾ï»ó½ÇÁõÈıº
  • amniotic band syndrome
    ¾ç¸·¶ìÁõÈıº
  • anginal syndrome
    Çù½ÉÁõÁõÈıº
  • angioosteohypertrophy syndrome
    Ç÷°ü»ÀºñÈÄÁõÈıº
  • anterior interosseous nerve syndrome
    ¾Õ»À»çÀ̽ŰæÁõÈıº
  • anterior spinal artery occlusion syndrome
    ¾Õô¼öµ¿¸ÆÆó»öÁõÈıº
  • anxiety syndrome
    ºÒ¾ÈÁõÈıº
  • aortic arch syndrome
    ´ëµ¿¸ÆÈ°ÁõÈıº
  • apallic syndrome
    ´ë³ú°ÑÁú»ó½ÇÁõÈıº
  • aqueous mis-direction syndrome
    ¹æ¼öÈ帧ÀÌ»óÁõÈıº
  • asphyctic syndrome
    Áú½ÄÁõÈıº
  • atomic bomb syndrome
    ¿øÀÚÆøÅºÁõÈıº
  • auriculotemporal syndrome
    ±Ó¹ÙÄû°üÀÚÁõÈıº
  • basal cell nevus syndrome
    ¹Ù´Ú¼¼Æ÷¸ð¹ÝÁõÈıº, ±âÀú¼¼Æ÷¸ð¹ÝÁõÈıº
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • immunological deficiency state
    ¸é¿ª°áÇÌ »óÅÂ.
  • inosine phosphorylase deficiency
    À̳ë½ÅÆ÷½ºÆ÷¸±¶óÁ¦°áÇÌ(Áõ)
  • phosphate dehydrogenase deficiency
    Àλ꿰ݼö¼ÒÈ¿¼Ò°áÇÌÁõ
  • pituitary deficiency
    ÇϼöüºÎÀü(¡­ÝÕîï).
  • pituitary deficiency
    üºÎÀü(ù»á÷ô÷ÝÕîï)
  • pituitary hormone deficiency (pituitary dwarfism)
    ³úÇϼöüȣ¸£¸ó°áÇÌ (³úÇϼöü³­
  • protein-calorie deficiency
    ´Ü¹é(Áú)¿­·®°áÇÌ(Ó±ÛÜ(òõ)æðÕáÌÀù¹)
  • pyridoxine deficiency
    ÇǸ®µ¶½Å°áÇÌ(Áõ)(¡­ÌÀù¹(ñø))
  • reaction deficiency
    ¹ÝÀÀ°áÇÌ
  • Browns syndrome->superior oblique tendon sheath syndrome
    ºê¶ó¿îÁõÈıº
  • Cowdens syndrome = multiple hamartoma syndrome
    ´Ù¹ß¼º °ú¿ÀÁ¾ ÁõÈıº
  • ICE syndrome=iridocorneal endothelial syndrome
    ȫä°¢¸·³»ÇÇÁõÈıº
  • Lowes syndrome->oculocerebrorenal syndrome
    ·Î¿ìÁõÈıº
  • PIE syndrome => pulmonary infiltration with eosinophilia syndrome
    È£»ê±¸Áõ°¡¼º ÆóħÀ± ÁõÈıº
  • Q-T prolongation syndrome ; long Q-T syndrome
    Q-T°£°Ý ¿¬ÀåÁõÈıº.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • immunity pattern
    ¸é¿ª¾ç½Ä, ¸é¿ªÇü.
  • immunity ³ª immunitas
    ¸é¿ª(¼º)(Øóæ¹àõ).
  • immunity, acquired
    ȹµæ¸é¿ª, ÈÄõ¼º¸é¿ª
  • immunity, active
    ´Éµ¿¸é¿ª
  • immunity, adoptive
    ÀÔ¾ç¸é¿ª, ÀÌÀԸ鿪
  • immunity, antibacterial
    Çױո鿪
  • immunity, antitoxic
    Ç×µ¶¼Ò¸é¿ª
  • immunity, antitumor
    Ç×Á¾¾ç¸é¿ª
  • immunity, antiviral
    Ç×¹ÙÀÌ·¯½º¸é¿ª
  • immunity, cell-mediated
    ¼¼Æ÷¸Å°³¸é¿ª
  • immunity, concomitant
    ¼ö¹Ý¸é¿ª, ºÎ¼ö¸é¿ª
  • immunity, cross
    ±³Â÷¸é¿ª
  • immunity, gut
    Àå°ü¸é¿ª
  • immunity, herd
    Áý´Ü¸é¿ª, ±ºÁý¸é¿ª, ¹«¸®¸é¿ª
  • immunity, humoral
    ü¾×¼º¸é¿ª
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
CR calculation rate; calculus removed; calorie-restricted; cardiac rehabilitation; cardiac resuscitatio...
CRABP cellular retinoic acid-binding protein
CRBP cellular retinol-binding protein
LDCC lectin-dependent cellular cytotoxicity
MICC mitogen-induced cellular cytotoxicity
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
CELISA cellular enzyme linked immunosorbent assay
CNBP cellular nucleic acid binding protein
CRBP I cellular retinol binding protein I
ECD extra cellular domain
Ca++ extra-cellular
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • absent pulmonary valve syndrome
    Æó µ¿¸Æ ÆÇ °á¿© ÁõÈıº
    ´Üµ¶À¸·Î ÀϾ´Â °æ¿ì´Â ±ØÈ÷ µå¹°¸ç, ½É½Ç Áß°Ý °á¼Õ, ¿ì½Ç ´©µÎºÎ ÇùÂø¿¡ ÇÕº´ÇÏ´Â °æ¿ì°¡ ºñ±³Àû ¸¹´Ù. Áï Fallot 4ÁõÈÄÀÇ ÇÕº´ ±âÇüÀ¸·Î ³ªÅ¸³­´Ù. ÀÌ °æ¿ì ÁÂ¿ì Æóµ¿¸ÆÀÇ È®´ë, ¥±À½ Æóµ¿¸Æ ¼ººÐÀÇ ¿ÏÀü ¼Ò½Ç, ÇÇÄ¡°¡ ³·Àº È®Àå±â ÀâÀ½À» ³ªÅ¸³½´Ù. À̰ÍÀ» µ¿¹ÝÇÑ Fallot 4ÁõÈÄ´Â À¯¾Æ±â¿¡ ¿ïÇ÷¼º ½ÉºÎÀüÀ» ÀÏÀ¸Å°±â ½±´Ù.
  • absent testes syndrome
    °íȯ °á¿© ÁõÈıº
  • abstinence syndrome
    ±Ý´Ü ÁõÈıº
  • acid aspiration syndrome
    À§»ê ÈíÀÔ ÁõÈıº
  • acute HIV infection syndrome
    ±Þ¼º ÀÎü ¸é¿ª °áÇÌ ¹ÙÀÌ·¯½º Áúȯ °¨¿° ÁõÈıº
  • acute muscle compartment syndrome
    ±Þ¼º ±Ù±¸¿ª ÁõÈıº
    °ñÀý, ºÎÁ¾, ÃâÇ÷¿¡ ´ëÇÑ ¼Ó¹ß¼ºÀ¸·Î ±Ù±¸¿ª³»ÀÇ ºÎÇǰ¡ ±Þ¼ºÀ¸·Î Áõ°¡ÇÏ¿© ¸ð¼¼Ç÷°üÀÌ ¾Ð¹ÚÀ» ¹Þ¾Æ ¹ß»ýÇÑ ±Ù±¸¿ª ÁõÈıº.
  • acute respiratory distress syndrome
    ±Þ¼º È£Èí°ï¶õ ÁõÈıº
    ¼ºÀΠȣÈíºÎÀü, ¼ï Æó, ¹Ì¸¸¼º ÆóÆ÷ ¼Õ»ó, ±Þ¼º ÆóÆ÷ ¼Õ»ó, ¿Ü»ó¼º ÀæÀº Æó µîÀÌ ÀÖ´Ù. ¹Ì¸¸¼ºÀ¸·Î ÆóÆ÷ ¸ð¼¼Ç÷°üÀÌ ¼Õ»óÀ» ÀÔ¾î ÃÊ·¡µÇ¸ç ÀÓ»óÀûÀ¸·Î´Â ±Þ°ÝÈ÷ »ý±ä ½ÉÇÑ È£Èí°ï¶õ, ºó¸Æ, û»öÁõ ¹× »ê¼Ò¿ä¹ý¿¡ ¹ÝÀÀÇÏÁö ¾Ê´Â µ¿¸Æ Àú»ê¼ÒÁõ µîÀ» Ư¡À¸·Î ÇÑ´Ù.
  • adaptation syndrome
    ÀûÀÀÁõÈıº, Á¶ÀýÁõÈıº
    »ýü¿¡ ¿Ü·ÂÀÌ °¡ÇØÁö¸é, ºÎ½Å ÇÇÁú°è, ³úÇϼöü°¡ Ȱµ¿ÇÏ¿© ºÎ½Å ÇÇÁú È£¸£¸óÀÌ °ú·® ºÐºñµÇ¾î ¿Ü·Â¿¡ ÀúÇ×Çϴµ¥, ÀÌ È°µ¿ÀÇ Á¤µµ¿¡ µû¶ó °¢Á¾ ÁúȯÀÌ À¯¹ßµÈ´Ù´Â °³³ä.
  • adrenal Cushing's syndrome
    ºÎ½Å Äí½Ì ÁõÈıº
    °úÀ×ÀÇ ÄÚ¸£Æ¼ÄÚÀ̵忡 ÀÇÇØ ³ªÅ¸³ª´Â Áõ»óÀ» ÀÏÄÃÀ¸¸ç ´ë°³ ´çÁú ÄÚ¸£Æ¼ÄÚÀ̵åÀÇ °ú¿ë·®¿¡ ÀÇÇØ »ý±â°í ºÎ½Å ÇÇÁúÀÇ ÄÚ¸£Æ¼ÄÚÀÌµå »ý»ê¿¡ ÀÇÇÑ °æ¿ì´Â µå¹°´Ù. ÀÚ¿¬ ¹ß»ýÀÇ Äí½Ì ÁõÈıºÀº ¼ºÀÎÀÇ °æ¿ì ´ÙÀ½°ú °°Àº °¡´É¼ºÀÌ ÀÖ´Ù. 1
  • adrenal virilizing syndrome
    ºÎ½Å¼º ³²¼ºÈ­ ÁõÈıº
  • adrenogenital syndrome
    ºÎ½Å ¼º±â ÁõÈıº
    1. ºñÁ¤»óÀ¸·Î ´Ù·®ÀÇ ¾Èµå·ÎÁ¨¼ºÀÇ ½ºÅ×·ÎÀ̵å, ƯÈ÷ µðÇÏÀ̵å·Î ¿¡ÇǾȵå·Î½ºÅ×·ÐÀÌ ºÎ½ÅÀ¸·ÎºÎÅÍ ºÐºñµÇ¾î ±× °á°ú ³²¾Æ¿¡¼­´Â Á¶¼÷Áõ, ¿©¾Æ¿¡¼­´Â ³²¼ºÈ­¸¦ ÀÏÀ¸Å²´Ù. °¡Àå ÈçÇÑ ¿øÀÎÀÌ 21?-hydroxylaseÀÇ ¼±Ãµ¼º °áÇÌ. ¸Å¿ì µå¹°°Ô »ý¸íÀ» ÀÒ°Ô µÇ´Â °æ¿ì°¡ Àִµ¥ ÀÌ´Â 2?-dehydroxylaseÀÇ ¿ÏÀü °áÇÌÀÌ ¿øÀÎÀÌ´Ù. 2. ºÎ½Å ÇÇÁúÀÇ ±â´É Ç×Áø¿¡ ÀÇÇÑ ÁõÈıºÀ¸·Î ¿©¼º¿¡¼­´Â ÀϹÝÀûÀ¸·Î Ãâ»ý ½Ã¿¡ °¡¼º ¹ÝÀ½¾ç ³²¼ºÈ­°¡ ÀÖ°í, ³²¼º¿¡¼­´Â ¼ºÀû Á¶¼÷À» º¸À̳ª »ýÈÄ 3-4³â Àü¿¡´Â ÃâÇöÇÏÁö ¾Ê´Â´Ù. À̵é ÀÓ»ó ¼Ò°ßÀº ÄÚ¸£Æ¼¼ÕÀÇ »ý»ê °áÇ̰ú ¾Èµå·Î°ÕÀÇ »ý»ê °úÀ׿¡ ÀÇÇÏ¿© ³ªÅ¸³­´Ù.
  • adrenosympathetic syndrome
    ºÎ½Å ±³°¨½Å°æ ÁõÈıº
    Àϰú¼º °íÇ÷¾Ð, ´ç´¢, ½É¹Ú ±Þ¼Ó, ¾È»öº¯È­, µÎÅë, ±¸±â, ±¸Åä µîÀÇ ¾Æµå·¹³¯¸° Áßµ¶À» ¿¬»óÄÉ ÇÏ´Â ÁõÈıºÀ¸·Î, ºÎ½Å ¼öÁúÀÇ Å©·Ò ģȭ ¼¼Æ÷Á¾¿¡¼­ º¼ ¼ö ÀÖ´Ù.
  • adult respiratory distress syndrome
    ¼ºÀμº È£Èí°ï¶õ ÁõÈıº
    ¿Ü»ó ¸çÄ¥ ÈÄ¿¡ ¹ß»ýÇÏ´Â °©ÀÛ½º·¯¿î Æó °£Áú ¹× ÆóÆ÷ÀÇ ºÎÁ¾. ÀÌ´Â ³ú ¼Õ»ó ȤÀº Àú»ê¼ÒÁõ¿¡ ÀÇÇØ »ý±â´Â °ú°ÝÇÑ ±³°¨½Å°æ°è Ç×Áø ¶Ç´Â ¸ð¼¼Ç÷°ü Åõ°ú¼ºÀÇ Áõ°¡°¡ ¿øÀÎÀ¸·Î »ý°¢µÈ´Ù.
  • aeroadaptation syndrome
    Ç×°ø ¼øÀÀ ÁõÈıº
  • Aicardi's syndrome
    ¿¡Ä«¸£µð ÁõÈıº
    ¿©¾Æ Á¥¸ÔÀÌ¿¡ ³ªÅ¸³ª´Â ÁõÈÄ·Î ³ú·®Ã¼ÀÇ ¹«¹ßÀ°, »ê¹ßÀûÀÎ ¸Æ¶ô¸· ¸Á¸· º´º¯, ±ÙÀ° °æ·Ã°ú ±äÀ强 Á¤½Å °æ·Ã, Á¤½Å ¹ßÀ° Áöü°¡ Ư¡ÀÌ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
glucose-6-phosphate dehydrogenase deficiency A deficiency of glucose-6-phosphate dehydrogenase, an enzyme important for maintaining cellular concentrations of reduced nucleotides.
Deficiency of this enzyme is the commonest disease-causing enzyme defect in humans affecting an estimated 400 million people.
The gene for this enzyme is on the X chromosome and there are various polymorphic forms.
Males with the enzyme deficiency develop haemolytic anaemia when red blood cells are exposed to oxidant drugs such as the antimalarial primaquine, the sulfonamide antibiotics or sulfones, naphthalene moth balls, or fava beans. It can also cause anaemia of the newborn, and chronic nonspherocytic haemolytic anaemia.
Inheritance: X-linked.
(12 Sep 2002)
vitamin k deficiency A nutritional condition produced by a deficiency of vitamin k in the diet, characterised by an increased tendency to haemorrhage (haemorrhagic diathesis). Such bleeding episodes may be particularly severe in newborn infants.
(12 Dec 1998)
glucosephosphate dehydrogenase deficiency A disease-producing enzyme deficiency subject to many variants, some of which cause a deficiency of enzyme activity in erythrocytes, leading to haemolytic anaemia.
(12 Dec 1998)
glucosephosphate isomerase deficiency <enzyme> An enzyme deficiency characterised by chronic nonspherocytic haemolytic anaemia; autosomal recessive inheritance.
Synonym: phosphohexose isomerase deficiency.
(05 Mar 2000)
glutathione synthetase deficiency An inborn error of metabolism associated with massive urinary excretion of 5-oxyproline, elevated levels of 5-oxyproline in the blood and cerebrospinal fluid, severe metabolic acidosis, tendency toward haemolysis, and defective central nervous systems function. Glutathione synthetase deficiency has been reported as a generalised condition or with a deficiency restricted to erythrocytes.
(05 Mar 2000)
mental deficiency Subnormal intellectual functioning which originates during the developmental period and is associated with impairment of one or more of the following: (1) maturation, (2) learning, (3) social adjustment.
(12 Dec 1998)
riboflavin deficiency A dietary deficiency of riboflavin causing a syndrome chiefly marked by cheilitis, angular stomatitis, glossitis associated with a purplish red or magenta-coloured tongue that may show fissures, corneal vascularization, dyssebacia, and anaemia.
(12 Dec 1998)
choline deficiency A condition produced by a deficiency of choline in animals. Choline is known as a lipotropic agent because it has been shown to promote the transport of excess fat from the liver under certain conditions in laboratory animals. Combined deficiency of choline (included in the b vitamin complex) and all other methyl group donors causes liver cirrhosis in some animals. Unlike compounds normally considered as vitamins, choline does not serve as a cofactor in enzymatic reactions.
(12 Dec 1998)
phosphohexose isomerase deficiency <enzyme> An enzyme deficiency characterised by chronic nonspherocytic haemolytic anaemia; autosomal recessive inheritance.
Synonym: phosphohexose isomerase deficiency.
(05 Mar 2000)
placental sulfatase deficiency <enzyme> An enzyme defect in the placenta which results in failure of conversion of 16a-hydroxydehydroepiandrosterone to estriol; women with this condition rarely enter into spontaneous labour.
(05 Mar 2000)
platelet storage pool deficiency A group of disorders characterised by a decrease or lack of platelet dense bodies in which the releasable pool of adenine nucleotides and 5ht are normally stored.
(12 Dec 1998)
congenital antithrombin III deficiency Antithrombin III is a protein which stimulates the removal of blood clots in the bloodstream. Small blood clots form normally within the bloodstream, but are normally dissolved via the bodys antithrombin III. The deficiency of antithrombin III will result in an increased risk for blood clot formation causing organ damage. This is an inherited as a autosomal dominant trait.
Inheritance: autosomal dominant.
(27 Sep 1997)
multiple carboxylase deficiency Abnormalities in carbohydrate and branched-chain amino acid catabolism that are responsive to biotin therapy. It may be due to deficiency of propionyl-CoA carboxylase, methylcrotonyl-CoA carboxylase, biotinidase, or propionyl-CoA carboxylase, methylcrotonyl-CoA carboxylase, and pyruvate carboxylase.
(12 Dec 1998)
congenital protein C or s deficiency This inherited disorder of blood coagulation is characterised by a deficiency of vitamin K dependent plasma proteins (C and s) that are naturally occurring anticoagulants. This disorder results in an increased risk of blood clot formation within the circulatory system.
(27 Sep 1997)
multiple sulfatase deficiency An inherited disorder (autosomal recessive) in which there is a failure to hydrolyze sulfatides and sulfated mucopolysaccharides; this failure leads to their accumulation in neural and extraneural tissues causing demyelination, sulfatiduria, facial and skeletal dysmorphism, etc.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
ÅëÇÕ°Ë»ö ¿Ï·á